Evidence map›Paper›PMID 38994915›Full record

ArticleJournal of the American Chemical Society2024

Palladium-Catalyzed Addition of Aryl Halides to

Ming-Kai Wei, Daniel F Moseley, Robin M Bär, Yeshua Sempere, Michael C Willis

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ming-Kai WeiDepartment of Chemistry, University of Oxford, Mansfield Road, Oxford OX1 3TA, United Kingdom.
Daniel F MoseleyDepartment of Chemistry, University of Oxford, Mansfield Road, Oxford OX1 3TA, United Kingdom.
Robin M BärResearch & Development, Crop Science, Bayer AG, Alfred-Nobel-Str. 50, Monheim am Rhein 40789, Germany.
Yeshua SempereResearch & Development, Crop Science, Bayer AG, Alfred-Nobel-Str. 50, Monheim am Rhein 40789, Germany.ORCID 0000-0002-4953-4666
Michael C WillisDepartment of Chemistry, University of Oxford, Mansfield Road, Oxford OX1 3TA, United Kingdom.ORCID 0000-0002-0636-6471

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sulfinamides are versatile, synthetically useful intermediates, and final motifs. Traditional methods to synthesize sulfinamides generally require substrates with preinstalled sulfur centers. However, these precursors have limited commercial availability, and the associated synthetic routes often require harsh reaction conditions and highly reactive reagents, thus severely limiting their application. Herein, we report the synthesis of sulfinamides from aryl and alkenyl (pseudo)halides and

Identifiers

PMID38994915
PMCPMC11273345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.